SAN FRANCISCO--(BUSINESS WIRE)--
JMP Group Inc. (NYSE:JMP),
an investment banking and alternative asset management firm, announced
today that Ronald V. Josey III and John L. Newman have joined
JMP Securities as equity research analysts. Mr. Josey, a managing
director, covers the Internet industry, while Mr. Newman, a director,
follows biotechnology. Both analysts are based in the firm's New York
"We are very pleased that Ron Josey has joined JMP," said Mark Lehmann,
president of JMP Securities. "He is well regarded by the institutional
investment community as a result of a technology-focused career that has
spanned management consulting, business development and equity research.
His background provides him with a multifaceted perspective on the
Internet sector and its constituent parts, including consumer Internet
and e-commerce, online advertising, social media and the mobile Internet.
"John Newman is also an important addition to our research platform. His
arrival deepens and broadens JMP's coverage of the biotech industry, an
area that has been one of our key focuses for many years. Working
alongside Liisa Bayko and Jason Butler, John will enhance the firm's
reputation for excellence in the sector and its ability to serve a very
specialized group of healthcare investors."
Prior to joining JMP Securities, Mr. Josey served as a senior research
analyst at ThinkEquity LLC, where he focused on Internet subsectors such
as e-commerce, online advertising, mobile Internet, online video and
online travel. He was previously a vice president in equity research at
Barclays Capital and its predecessor, Lehman Brothers, with coverage of
small- and mid-cap Internet stocks. Mr. Josey also worked as a business
development and marketing manager at AOL, concentrating on product
strategy and development. He began his career as a consultant in the
communications and high technology market unit at Accenture. Mr. Josey
holds an MBA from The Robert H. Smith School of Business at University
of Maryland and a BS from Villanova University.
Prior to joining JMP Securities, Mr. Newman was a senior research
analyst covering biotechnology and specialty pharmaceuticals at WJB
Capital. He previously served in the same capacity at Citadel Securities
and Oppenheimer & Co. He began his financial services career at Merrill
Lynch, where he served in the equity research department as part of an
award-winning biotechnology team. Beforehand, Mr. Newman was a
postdoctoral fellow in biochemistry at University of Wisconsin—Madison
after receiving his PhD in chemistry from University of Maryland. He
holds a BS from Loyola University Chicago.
About JMP Group
JMP Group Inc. is a full-service investment banking and asset management
firm that provides investment banking, sales and trading, and equity
research services to corporate and institutional clients as well as
alternative asset management products to institutional and
high-net-worth investors. JMP Group operates through three subsidiaries:
JMP Securities, Harvest Capital Strategies and JMP Credit Advisors. For
more information, visit www.jmpg.com.
JMP Group Inc.
Andrew Palmer, 415-835-8978 (Investors)
Seth Linden, 212-704-7385 (Media)
Leibowitz, 212-704-7385 (Media)
Source: JMP Group Inc.
News Provided by Acquire Media